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The aim of this study was to assess how demographic variables and personal
values are related to people’s knowledge and cognitive and behavioural responses
towards a major drug recall event that occurred in Australia in 2003. For this
purpose, a survey was sent out in 2003 to 1000 households in Victoria, Australia.
Households had been randomly selected from the electoral role. A total of
415 respondents participated. Results indicated that higher socioeconomic status
was related to better information about the recall event and more trust in
manufacturers. Respondents who held traditional or naturalistic values were
likely to trust that faults in the system would be regulated by the government or
consumers themselves. Parents and older respondents were more likely to be
critical of the Therapeutic Goods Administration which co-ordinated the recall.
Parental status, education and values were related to subsequent changes in
respondents’ use of complementary medicines. In light of the worth of the health
supplement industry to the Australian economy, the results of this survey suggest
that the Therapeutic Goods Administration should adopt a more transparent and
accountable role towards the public.
Keywords: drug recall; Therapeutic Goods Administration; policy; public trust;
transparency; Australia
In April 2003 the Therapeutic Goods Administration (TGA) of Australia withdrew
approximately 1600 supplementary products and over-the-counter medicines manufac-
tured by Pan Pharmaceuticals from sale (Australian Government 2003a, 2003b). This
recall constituted the largest recall of health care products in Australian and, possibly, in
world history (Worth 2003). The recall was triggered by consumer reports of adverse
effects after consumption of an over-the-counter drug designed to combat motion sickness
which had been manufactured by Pan Pharmaceuticals, Travacalm Original. Analysis of
the product established that tablets contained up to seven times the required amount
of the active stated ingredient, hyoscine hydrobromide. An overdose of this ingredient
can cause, among other things, confusion, hallucinations, anxiety, and dizziness
(McEwen et al. 2007).
Therapeutic goods are regulated under the Therapeutic Goods Act 1989. The
administration of the provisions of the Act falls under the responsibility of the TGA.
The legislation specifies that regulatory control of therapeutic goods be exerted through
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three processes: pre-market assessment of goods; post-market vigilance; and licensing of
manufacturers through adherence to a Code of Good Manufacturing Practice (GMP)
(TGA 2002, Australian Government 2005).
Once a therapeutic good has satisfied pre-market assessment, it is either registered or
listed with the Australian Register of Therapeutic Goods and can then be supplied on the
Australian market or exported to other countries. Registration applies to prescription
medicines as well as some over-the-counter medicines and involves a high level of
evaluation concerning the medicine’s quality, safety and efficacy. Listed goods generally
are regarded as being a lower safety risk. These goods make lower level claims and do not
contain any scheduled poisons. Most complementary medicines are listed goods and are
evaluated for quality and safety only (TGA 2002, Australian Government 2004a). In
general, post-market vigilance for listed goods is less rigorous than for registered good
(Australian Government 2004b).
Adherence to GMP requires manufacturers to keep auditable and transparent
documentation of a therapeutic good’s manufacture and quality assurance testing (TGA
2002). Audits are conducted at an average frequency of 24 months at manufacturing sites.
The actual frequency of audits can vary depending on a range of factors, among them the
type of product manufactured (Australian Government 2003c). Audits are often
announced to ensure the presence of appropriate staff and accessibility of documentation
(Phelps 2003).
Because audits are generally announced and occur relatively infrequently, the integrity
of the system depends on trust in companies to comply with regulations and to behave in
ethical ways towards consumers. This approach is reflective of a preference by the
government to achieve public policy objectives through co- and self-regulation (Lofgren
and de Boer 2004). The integrity of the system broke down when, according to the TGA,
Pan Pharmaceuticals presented deliberately manipulated test data to authorities
(Australian Government 2003d, Jones 2003). Subsequently, the manufacturing licence of
Pan Pharmaceuticals was suspended (Australian Government 2003a).
While the suspension of Pan’s licence was triggered by the faultiness of an over-the-
counter product, most of the recalled products were complementary, listed medicines.
Until the recall, Pan Pharmaceuticals had been Australia’s largest contract manufacturer
of complementary medicines, an industry worth $AUS1 billion in Australia alone (Cohen
2003). The fact that most of the recalled goods were complementary medicines had the
potential of undermining public trust in this type of medicines. Critics also accused the
TGA of pursuing an unnecessarily heavy-handed approach to complementary medicines
(Kedgley 2003, Allison 2006).
Considering that about 60% of Australian consumers are at least infrequent users of
complementary medicines (Jones 2003), this recall episode offered the unique advantage of
investigating the responses of the public. The consumer response to the recall can be
thought of as being composed of a behavioural component and a cognitive component. In
terms of behaviour, people might have discontinued their use of complementary medicines,
or switched to a brand they believe to be safe. On a cognitive level, the recall episode might
have motivated people to form an opinion on existing regulations regarding supplemen-
tary medicines, on the role of the TGA, or the role of the government.
The general public comprises people who differ on characteristics such as gender,
education or income. Previous research suggests that women and tertiary-educated
people tend to be more interested in family health care (Wardle et al. 2000). We thus
expected them to be more knowledgeable of, and affected by, the Pan recall than men or
less-educated people.
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People also differ in the personal values to which they adhere. Values are considered to
be guiding principles in people’s lives that are used to evaluate objects, other people and
events (Schwartz 1992). Differences in personal values have been linked to differences in
food and health concerns (Feather et al. 1998, Worsley and Skrzypiec 1998), trust in
sources of nutrition information (Worsley and Lea 2003) and to differences in dietary
supplement use (Grotkowski and Sims 1978, Worsley and Worsley 1989). We hypothesised
that several values might moderate people’s responses to the recall episode. Universalism
(exemplified by the desire to protect the natural environment); Tradition-Conformity
(often defined as the motivation to subordinate the self in favour of socially imposed
expectations); Power or Achievement (the striving to demonstrate competence in everyday
interaction and to achieve status); and Hedonism (the seeking of pleasure or sensuous
gratification for oneself).
The relationship between socio-demographic characteristics and values, and people’s
knowledge of the recall event as well as their behavioural and cognitive responses to the
recall was investigated through a survey.
Method
Procedure
An omnibus survey aimed at eliciting people’s views of sports foods and vitamin
supplements was sent to a total of 1000 households that had been randomly selected from
the Victorian Electoral Roll, on which registration is compulsory for all citizens aged
18 years and over. The survey was administered in 2003, approximately 3 months after the
recall. Two reminders (including a final replacement survey form) were sent to respondents
at fortnightly intervals. The questionnaire contained a section about the Pan
Pharmaceutical episode, a short personal values scale, as well as questions aimed at
eliciting background information. A total of 415 respondents (178 men, 234 women and
3 respondents who did not indicate their gender) returned completed surveys. After
allowing for non-deliveries, this constituted a 41.5% response rate.
Measures
Items relating to the Pan Pharmaceuticals recall episode
This section consisted of 14 questions in open as well as closed response format. Questions
assessed the following:
. respondents’ knowledge of the recall episode;
. the ways respondents were affected by it (if at all);
. the ways respondents had changed their use of complementary medicines
(if at all);
. respondents’ beliefs about the cause of the company problem;
. their opinion about the way in which the TGA had dealt with the Pan problem;
. their views regarding the control of the sale of dietary supplements;
. their opinions of possible government responses to the recall;
. the perceived safety of complementary medicines;
. the brands respondents trusted most and least; and
. the most likely outcomes of the recall episode.
A copy of the questionnaire can be obtained from the authors.
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Personal values
The abbreviated personal value scale was adapted from the Schwartz Personal Values
Inventory (Schwartz 1992) and consisted of 21 values. Respondents were asked to
indicate on a four-point scale ranging from ‘not’ to ‘very’ how important each of the
listed values is in their lives. The scale assessed four dimensions: Traditionalism,
Universalism, Hedonism and Power. Items defining each dimension were summed to
make value scores, as follows. Traditionalism consisted of eight items: devout,
detachment, obedient, national security, honour parents, self-discipline, family security
and social order (Cronbach’s ¼ 0.65). Power was defined by three items: social power,
authority and wealth (Cronbach’s ¼ 0.65); Hedonism by: pleasure, enjoying life,
exciting life, varied life and daring (Cronbach’s ¼ 0.74), and Universalism by: world
of beauty, protecting the environment, unity with nature, equality and inner harmony
(Cronbach’s ¼ 0.74).
Background information
This section assessed information relating to respondents’ gender, age, occupation, marital
status, education, parental status, ethnicity and income.
Statistical analyses
Analyses were conducted using SPSS version 11.5 (SPSS 2003). The relationships
of selected socio-demographic variables with categorical variables relating
to the Pan recall were assessed via contingency table analyses. For the
purpose of retaining sufficient numbers for these analyses, the following variables
were recoded.
For the question ‘How could the government ensure that this doesn’t happen
again?’ response categories ‘It cannot’ and ‘It will not’ were collapsed into one, due to
the small number of respondents (five) who selected ‘It will not’. Similarly, for the
question ‘Generally, how safe are complementary medicines?’ response categories ‘I
don’t know’ and ‘Not safe’ were collapsed due to only eight respondents answering
‘Not safe’. The following items were transformed into dichotomous variables: Level of
schooling (no tertiary education versus tertiary education), marital status (married or
living together versus separated, divorced, widowed or never married) and ethnicity
(Anglo-Australian versus all other ethnic backgrounds). Age was split into tertiles:
1¼ up to 39 years, 2¼ 40–55 years, and 3¼ over 55 years. Out of four income groups
(1) up to AUS$30,000.–, (2) AUS$30,001.– to AUS$50,000.–, (3) AUS$50,001.– to
AUS$80,000.–, (4) AUS$80,001.– or more, it was decided to contrast only the lowest
with the highest income group. Respondents’ scores on the four personal values
dimensions were split into tertiles, thus deriving low, medium or high score categories.
Respondents who had indicated that they had heard about the recall episode had been
asked to specify what the recall was about. Responses were assessed by two
independent raters and coded as (1) correct information provided, or (2) incorrect
information provided. Cases where respondents had not elaborated what the recall
was about despite having indicated that they had heard about the recall were declared
missing. Respondents’ open replies regarding their opinion about the TGA were
coded into three categories: neutral (1), critical of the TGA (2) and approving of
the TGA (3).
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Results
Demographic characteristics of the sample
The demographic characteristics of the sample are displayed in Table 1. Figures from
the 2001 Census (Australian Bureau of Statistics 2002) indicate that women were slightly
over-represented compared to men, and that single persons were under-represented
compared to couples. In other regards, the sample appears to be representative of the
wider Victorian population.
Contingency table analyses
Almost all of the respondents had heard about the Pan recall episode. This knowledge
was not, however, evenly distributed. As Table 2 shows, respondents from an
Anglo-Australian background were more likely to have heard about the recall than
respondents from other ethnic backgrounds. A higher percentage of respondents in the
highest income group had heard about the recall compared to respondents from the lowest
income group, and university-educated respondents were also more likely to have heard
about the recall than respondents without university education.
A high percentage of respondents (86.7%) provided an answer to the question, ‘What
was the recall about?’ The reason for the recall was correctly identified in 97% of cases.
Only income was significantly related to informed knowledge about the recall
(2(1)¼ 4.30, p5 0.05). Respondents whose annual household income was over
Table 1. Demographic characteristics of the respondents.
n Valid %
Gender 412
Men 178 43.2
Women 234 56.8
Age 388
Up to 39 years 134 34.5
40–55 years 135 34.8
More than 55 years 119 30.7
Household income in AUS$ 354
Up to 30,000.– 85 24.0
30,001.– to 50,000.– 65 18.4
50,001.– to 80,000.– 113 31.9
80,001.– or more 91 25.7
Ethnicity 396
Anglo-Australian 259 65.4
Other ethnic background 137 34.6
Education 406
Non university-educated 248 61.1
University-educated 158 38.9
Parental status 408
Parent 292 71.6
Non-parent 116 28.4
Marital status 403
Married or living together 289 71.7
Single 114 28.3
N¼ 415.
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AUS$80,000.– were more likely to hold correct knowledge (95.5%) than were respondents
whose annual household income was AUS$30,000.– or less (86.3%).
Of those respondents who answered the question ‘Were you personally affected by this
recall event’ (99.0%), only 11.2% responded in the affirmative. Responses to this question
were not significantly related to any of the other variables under investigation.
The percentage of respondents who indicated that they had changed their use of
complementary medicines was similar to that of respondents who reported that they had
been personally affected by the recall event. A change in the use of complementary
medicines was related to being a parent, not being university-educated, and obtaining high
scores on Tradition or Universalism (Table 3).
Almost half of those who provided a valid response to the question ‘What is your
opinion of the actions of the Therapeutic Goods Administration which regulates these
products? How do they come out of this episode?’ were critical of the TGA, while an
approximately equal percentage of respondents had either no opinion or commented
positively about the TGA. Respondents aged 40 years or more were more likely to hold an
opinion about the TGA than respondents in the lowest age group (Table 4).
Respondents in all age groups were more likely to view the TGA in a critical light
rather than favourably. This was particularly true for respondents in the two older age
groups.
Parents were more likely to hold an opinion about the TGA than were non-parents.
The opinion of both parents and non-parents towards the TGA was more likely to be
critical than favourable, although this was far more pronounced for parents.
Almost all respondents (96.9%) answered the multiple-choice question about the
adequacy of the controls on the marketing of dietary supplements. More than half (55.0%)
held no opinion about it. Most of those who did hold an opinion (36.9%) thought the
marketing of dietary supplements to be poorly regulated, while only a minority (7.0%)
perceived it to be well controlled. Neither socio-demographic characteristics nor personal
values were significantly related to respondents’ answers to this question.
Overall, 360 respondents or 86.7% of the total sample answered the closed question,
‘How could the government ensure that this doesn’t happen again?’ The majority (81.7%)
favoured stricter law enforcement, including more inspections of the manufacturing
process. The remainder were equally split among those who thought that the government
Table 2. The relationship between knowledge about the recall episode and ethnicity, income and
education.
Heard about recall episode
Ethnicity n % 2
Anglo-Australian 257 96.9 8.56**
Other 137 89.8
Income
Up to $30,000. – 85 86.9 7.54**
$80,001. – or more 91 97.8
Education
Non university-educated 248 92.3 4.83*
University-educated 158 97.5
Total valid responses 413 94.4
Notes: * p50.05, ** p5 0.01.
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should monitor the effects of dietary supplements on the population better (9.2%), and
those who thought that the government either cannot or will not ensure that this event
does not repeat itself (9.2%).
Most respondents (97.3%) answered the question, ‘Generally, how safe
are complementary medicines?’ Respondents from high-income households as
well as the tertiary-educated indicated that the safety of complementary
medicines varies, while those in the lowest-income group and the non tertiary-educated
were more likely to consider these medicines as unsafe or had no opinion about
them (Table 5).
A question in multiple choice format asked respondents: ‘What do you believe
will happen next as a result of this episode?’ The distribution of responses is shown in
Table 6.
Income, education, Tradition and Universalism were all related to the opinion that the
recall episode will have various types of repercussions. Respondents in the highest income
Table 3. Relationships between reported change in the use of complementary medicines, parental
status, education, Tradition and Universalism.
Changed use of complementary medicines
Parental status n % 2
Is parent 292 15.6 3.87*
Is not parent 116 8.0
Education
Non-university educated 248 16.2 5.64*
University educated 158 7.9
Tradition
Low 140 7.1 8.69*
Medium 120 16.7
High 92 19.6
Universalism
Low 148 9.5 6.20*
Medium 95 10.5
High 114 19.3
Total valid responses 389 13.1
Note: *p5 0.05.
Table 4. The relationship between respondents’ opinion of the TGA and age and parental status.
Critical (%) Neutral (%) Positive (%) 2
Age group
Up to 39 years 36.9 40.8 22.3
40–55 years 53.8 16.0 30.2 19.16**
More than 55 years 52.4 19.5 28.0
Parental status
Is a parent 50.2 20.9 28.8 9.59**
Is not a parent 37.6 37.6 24.7
Total valid responses 46.0 26.4 27.7
Note: **p5 0.01.
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group were more likely to believe that manufacturers will face criminal proceedings
(48.4%) than respondents in the lowest income group (25.9%; (2(1)¼ 9.47, p5 0.01).
Similarly, the tertiary-educated were more likely to believe (43.7%) that the
manufacturers will face criminal proceedings as a result of the recall episode than
respondents who were not university educated (27.8%; 2(1)¼ 10.80, p5 0.01).
Respondents with university education were also more likely to indicate that
manufacturers will change their practices (32.3%) than respondents without university
education (19.8%) (2(1)¼ 8.15, p5 0.01).
Respondents who had medium or high scores on Tradition were more likely to
believe that the recall episode will cause the government to change the law (40.6% and
42.0%, respectively) than respondents who were low on Tradition (26.0%; (2(2)¼ 9.05,
p5 0.05). Respondents who scored medium or high on Tradition were more likely to
state that the recall will lead to an increase in fruit and vegetable sales (14.1% and
11.0%, respectively) than respondents who had scored low on Tradition (4.1%
;2(2)¼ 8.40, p5 0.05). Similarly, respondents who had obtained a high score on
Universalism were more likely to believe that the recall will lead to an increase in the
sales of fruit and vegetables (15.3%) than either respondents who had obtained a
medium or a low score on Universalism (5.05 and 7.6%, respectively; 2(2)¼ 8.01,
p5 0.05).
Table 5. The relationships between income and educational status and the perceived safety of
complementary medicines (% responses).
Perceived safety of complementary medicines
n Not safe/unknown Safe It varies 2
Income
Up to $30,000.-a 171 46.9 14.8 25.6 13.01**
$80,001.-a or more 21.1 25.6 53.3
Education
Non-university 395 42.7 15.5 41.8 8.14*
University 28.8 21.8 49.4
Total valid responses 404 37.4 17.8 44.8
Notes: *p5 0.05, **p5 0.01. ain Australian Dollars.
Table 6. Percentage of respondents agreeing or disagreeing with the question, ‘What do you think
will happen next as a result of this episode?’.
Yes No
It will simply go away and be forgotten. 24.3 75.7
The government will change the law regulating these products. 34.7 65.3
The manufacturer will change their practices
so that the government does not need to intervene.
24.3 75.7
The manufacturer will face criminal proceedings. 34.2 65.8
Consumers will stop using these products. 30.6 69.4
Sales of fruit and vegetables will increase. 9.2 90.8
Many natural therapists will become unemployed. 5.1 94.9
N¼ 415.
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Discussion
This survey offered a unique opportunity to study the reaction of the public to a major
breakdown in the regulatory system for medicines in Australia. The finding that almost all
of those surveyed had heard about the Pan-recall gives an indication about the breadth
and intensity of the media coverage of this event and the deep impression the recall episode
left on the public.
The results suggest that the public did not generalise Pan Pharmaceuticals’ breach of
GMP to other producers of supplementary medicines, as reflected in the very small
number of respondents (eight) who considered supplementary medicines unsafe. It is
possible that this finding can be attributed to the effects of an advertising campaign that a
leading health food and supplement manufacturer launched after the Pan event was made
public. This manufacturer tried to differentiate itself from Pan by emphasising in its
campaign that none of its products had been manufactured by Pan and were therefore safe
to take (Needham 2003). The subsequent rise in sales figures of the manufacturer
(NutraIngredients 2004) suggests that consumers of supplementary medicines switched to
producers they perceived to be trustworthy.
The food supplement industry thus appears to have been able to extricate itself from
the Pan affair. Conversely, the TGA also spent a lot of effort on public relations work
after the crisis, yet seems to have fared less well, its image having been tainted by the way it
handled the recall and the opinion that the TGA, together with pharmaceutical companies
had set out to discredit complementary medicines (Hillary 2003). This opinion is consistent
with findings of an analysis which reported that in the context of an era of neo-liberal
governance in Australia, the TGA has a diminished capacity to impose regulation
autonomously and unilaterally (Lofgren 2004), a finding not unique to Australia. The
circumstances associated with the safety of the drug Halcion in the Netherlands and the
UK were subject of a case study conducted by Abraham (2002). In this study, responses to
warnings about drug hazards by regulatory agencies, governmental expert advisers, the
pharmaceutical industry and the medical profession were examined. Abraham concluded
that, ‘manufacturers are unlikely to search effectively for compelling evidence against the
safety of their drugs and, therefore, that a regulatory system, which relies so extensively on
industrial self-examination is flawed’ (p. 1686). Considering that consumers have to rely
on regulators to ensure their protection, the TGA appears to be well advised to put more
effort into obtaining the trust of the Australian public. An increase in the transparency of
regulatory practice, as well as participation and consultation by independent non-experts
in regulatory decision-making has been suggested as a possible approach to improve public
confidence (Abraham and Sheppard 1997).
The results of this survey showed clear social economic strata differences, which
were rather complex in nature. Contrary to expectations, no gender differences
emerged. High-income earners, the tertiary-educated and respondents from an Anglo-
Celtic background had better knowledge of current affairs. Moreover, the knowledge of
high-income earners appeared to be deeper than that of low-income earners. On the
one hand, being on a high income or being tertiary-educated appears to have enabled
respondents to form considered opinions. This is suggested by the balanced stance that
respondents from these groups took towards the perceived safety of supplementary
medicines. On the other hand, the belief that manufacturers will face criminal
proceedings or change their practices as a result of the Pan episode was held more
strongly among the tertiary-educated and, in part, among those with high incomes. The
finding that the highly educated are less concerned about food and health issues, while
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running counter to the expectation that the tertiary-educated would have had a more
critical approach, is not new (Worsley and Scott 2000). Highly educated participants
appeared to hold a belief in a just world where the system is in good working order
and wrong-doers will get punished (Lerner 1965). This finding may be less surprising,
however, when the recent history of Australian politics is taken into account. The last
20 years or so have been characterised by a shift towards economic rationalism,
where increasing privatisation means that many Australians have become shareholders.
Lofgren and de Boer (2004) argue that the model for prescription drug regulation
in Australia has shifted from a protectionist version of the Keynesian welfare
national state to the competition state, which seeks to support the growth of
pharmaceutical industries to promote partnerships with business. People who live in a
system where their own vested interests are at stake not only have to keep up-to-date
with current affairs, but also have a need to trust the system to act in their own
best interest.
This interpretation finds support in research by sociologist Pusey (2003), who found
during in-depth interviews with focus groups in Australia that trust in others is indeed
highest among those who have profited the most from the economic reform. Those
who are apparently left out are the less-educated and the poor. These people lost out
under the system of economic rationalism and appear to have become distrustful and
cynical, perceiving supplementary medicines as unsafe and having changed their use of
these medicines. Also, these people are less likely to believe that any justice is likely to
be done. Overall, these opinions are testimony to a perception of powerlessness by the
poor and the less-educated. According to Pusey, these people are living through an
economic reform process that uses a top-down approach, thus effectively depriving
them of any sense of control. At a time where many Australians think that the
economy is driven by people whose sole aim is to maximise profit, the trust in
governments, employers, and corporations is gradually eroded. It is quite possible that
this loss in trust is an appropriate response to events, and that the response of the
highly educated and those who are well off is reflective of the interests of those who
seek to maintain the status quo.
Parents enter into this discussion as a separate group. They, too, have a vested interest
– the welfare of their children. Protection of their offspring may be the main reason that
parents were more likely to change the use of complementary medicines than were non-
parents. This is in line with a study by Jussaume and Judson (1992), who found that
households with children under the age of 18 were more concerned with food safety than
other households.
Parents, together with those aged more than 40 years, were also more likely to feel
angry towards the TGA. A significant relationship between age and parental status
(Spearman’s rho¼ 48, p5 0.001, n¼ 385) provides a partial explanation for this finding,
indicating that, in this sample, parents were more likely to be aged 40 years or more.
Considering that the relationship between age and parental status is far from perfect
means that, in part, parents and those aged over 40 were two separate groups who were
critical towards the TGA in their own right – parents because they give supplementary
medicines to their children, those over 40 years because being older is associated with an
increased likelihood of taking supplementary medicines.
The current research shows that not only demographic characteristics, but also the
values people hold are an important determinant of consumer behaviour and how
the system is being evaluated. Traditionalism and Universalism were both among the
values that had a bearing on participants’ expectations and behaviour. The finding that
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respondents who held traditional values expected the government to change the law as
a result of the recall episode is indicative of trust in the justness and the
reliable execution of legal control processes of the country. Trust in institutions has
been found in other research to be positively linked to values such as tradition (Devos
et al. 2002).
Several studies have shown that Universalism is associated with food-related health
concerns. People with strong environmental concerns were found to hold a negative
attitude to processed food (Worsley and Worsley 1989), a positive attitude to health and
organic products (Brunsø et al. 2004), and were concerned about food system problems
and hidden additives (Worsley and Skrzypiec 1998). Considering that Traditionalism
refers to acceptance of the customs and ideas that traditional culture provide (Jussaume
and Judson 1992), it is not surprising that Traditionalists as well as Universalists believed
one possible outcome of the Pan episode to be the increased sale of fruit and vegetables
and changed their use of supplementary medicines. It appears that, in light of a crisis,
Universalists turn back to nature und Traditionalists turn to things the past has to offer,
with both nature and the past being perceived as safe havens. These findings may not only
relate to the difference in values among consumers. Other studies have also reported a
divergence in views between experts and non-experts towards regulatory decision-making
on medicines in the UK with preference for ‘technocratic’ and ‘democratic’ approaches,
respectively, being explained by differences in values and the social frameworks guiding
perspectives (Abraham and Sheppard 1997).
Conclusion
Demographics and values were both associated with knowledge about and evaluation of
the Pan Pharmaceuticals recall event. Socioeconomically advantaged groups were found to
be more knowledgeable about the recall and less distrustful of the regulatory system.
Parents and older respondents were found to be more opinionated and hole a more critical
attitude towards the TGA. While various groups reported to have changed their use of
complementary medicines, this change appears not so much to have involved a turning
away from health supplement use, but rather the selection of products from manufacturers
which were perceived to be trustworthy.
Implications
Manufacturers, regulatory institutions and the government have to be aware that
public confidence in products may not be only determined by socio-demographic
characteristics, but also by the values that consumers hold. A need for better
communication by regulatory institutions is suggested by the finding that socio-
economically disadvantaged groups were less informed about the recall, and that this
lower level of information appeared to go hand-in-hand with increased negative
attitudes about the products in question and regulatory institutions. Parents and the
over 40s held unfavourable opinions of the TGA. These population groups constitute a
considerable percentage of the population and their opinions and attitudes cannot be
simply overlooked. Similarly, there is a need to communicate better with parents and
the over 40s who were critical of the TGA. In summary, we recommend that the TGA
becomes more accountable towards the broad public, and that corporate transparency
be increased.
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